Overview
The Cancer Target Discovery and Development (CTD²) Network is a functional genomics initiative that is bridging the gap between large-scale genomic datasets and the underlying etiology of cancer development, progression, and metastasis.
A Symposium of CTD² research will virtually be held on March 19, 2026. During the meeting, CTD² investigators will share studies of tumor heterogeneity, treatment resistance in cancer, and the preclinical development of new therapeutic strategies. They will also discuss computational and functional systems biology approaches for cancer research.
Goals for the Meeting:
- Highlight and promote CTD² Network science
- Foster interactions between CTD² investigators and the cancer research community
- Support CTD² program-specific opportunities
CTD² Symposium Session Themes:
- Cancer Biology
- Precision Oncology
- Technology Enablement
- Computational Biology
CTD² Symposium Planning Committee:
- Ron Depinho, M.D., MD Anderson Cancer Center
- Sean Hanlon, Ph.D., NCI Division of Cancer Biology
- Lucas Hu, Ph.D., Columbia University
- Christopher Kemp, Ph.D., Fred Hutch Cancer Center
- Claire McCarthy, Ph.D., NCI Division of Cancer Biology
- Michael McManus, Ph.D., UCSF
- Guangrong Qin, Ph.D., Institute for Systems Biology
If you have questions or would like additional information about the virtual CTD² Network Symposium, please contact Dr. Claire McCarthy (claire.mccarthy@nih.gov).